lisinopril

Generic: lisinopril

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lisinopril
Generic Name lisinopril
Labeler asclemed usa, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

lisinopril 5 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-341
Product ID 76420-341_342374a0-645e-e49e-e063-6394a90a2498
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076164
Listing Expiration 2026-12-31
Marketing Start 2011-11-01

Pharmacologic Class

Classes
angiotensin converting enzyme inhibitor [epc] angiotensin-converting enzyme inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420341
Hyphenated Format 76420-341

Supplemental Identifiers

RxCUI
197884 205326 311353 311354 314076 314077
UNII
E7199S1YWR

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lisinopril (source: ndc)
Generic Name lisinopril (source: ndc)
Application Number ANDA076164 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (76420-341-00)
  • 100 TABLET in 1 BOTTLE (76420-341-01)
  • 30 TABLET in 1 BOTTLE (76420-341-30)
  • 60 TABLET in 1 BOTTLE (76420-341-60)
  • 90 TABLET in 1 BOTTLE (76420-341-90)
source: ndc

Packages (5)

Ingredients (1)

lisinopril (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "342374a0-645e-e49e-e063-6394a90a2498", "openfda": {"unii": ["E7199S1YWR"], "rxcui": ["197884", "205326", "311353", "311354", "314076", "314077"], "spl_set_id": ["db5bfa2f-07b8-4f79-8a40-691da006e2ed"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (76420-341-00)", "package_ndc": "76420-341-00", "marketing_start_date": "20250502"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (76420-341-01)", "package_ndc": "76420-341-01", "marketing_start_date": "20250502"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-341-30)", "package_ndc": "76420-341-30", "marketing_start_date": "20250502"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-341-60)", "package_ndc": "76420-341-60", "marketing_start_date": "20250502"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-341-90)", "package_ndc": "76420-341-90", "marketing_start_date": "20250502"}], "brand_name": "LISINOPRIL", "product_id": "76420-341_342374a0-645e-e49e-e063-6394a90a2498", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]"], "product_ndc": "76420-341", "generic_name": "Lisinopril", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LISINOPRIL", "active_ingredients": [{"name": "LISINOPRIL", "strength": "5 mg/1"}], "application_number": "ANDA076164", "marketing_category": "ANDA", "marketing_start_date": "20111101", "listing_expiration_date": "20261231"}